In a study of 171 GC patients receiving neoadjuvant chemotherapy (NCT), FAP-positive CAFs were significantly associated with poor tumor regression grade (TRG) (P < 0.01) and worse overall survival in univariate analysis (P < 0.05). This evidence concerns the gene FAP and neoplasm.